MyWorldGo Infection Surveillance Solutions Market 2022: Industry Analysis, Opportunity Assessment and Forecast to 2027

Blog Information

  • Posted By : Marcel Mikaelson
  • Posted On : Apr 14, 2022
  • Views : 91
  • Category : General
  • Description : The global infection surveillance solutions market reached a value of US$ 514.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,158.50 Million by 2027, exhibiting at a CAGR of 13.30% during 2022-2027.

Overview

  • According to the latest report by IMARC Group, titled, “Infection Surveillance Solutions Market Growth: Global Industry Trends, Share, Size, Opportunity and Forecast 2022-2027“, the global infection surveillance solutions market reached a value of US$ 514.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,158.50 Million by 2027, exhibiting at a CAGR of 13.30% during 2022-2027.

    Infection surveillance solutions are a set of techniques employed in the healthcare industry. It is utilized by professionals for monitoring, acquiring, and interpreting the health reports of patients to ensure the accurate diagnosis and the implementation of preventive measures. It is further used for diagnosing antibiotic-resistant organisms (AROs) urinary tract, surgical wounds, and ventilator-associated pneumonia. At present, infection surveillance solutions are commercially available in two varying types, such as on-premises and cloud-based solutions.

    Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/infection-surveillance-solutions-market/requestsample

    Market Trends

    The global infection surveillance solutions market is primarily being driven by the rising prevalence of various contagious hospital-acquired infections, especially amongst the geriatric population. Additionally, the increasing utilization of infection surveillance solutions for identifying epidemics, accurate health details and surgical databases is contributing to the market growth. Besides this, the introduction of innovative solutions in analytics and data management is propelling the market growth. In line with this, the rising demand for cloud-based software is creating a positive outlook for the market.

    NoteWe are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

    Competitive Landscape:

    The competitive landscape of the industry has also been examined along with the profiles of the key players.

    • Baxter International Inc.
    • Becton Dickinson and Company
    • Centrak Inc. (Halma plc)
    • Cerner Corporation
    • CKM Healthcare Incorporated
    • Ecolab Inc.
    • International Business Machines Corporation
    • Medexter Healthcare
    • Perahealth Inc.
    • PointClickCare
    • Premier Inc.
    • Sunquest Information Systems Inc. (Roper Technologies Inc.).

    The report has segmented the market based on component, deployment type and end user.

    Breakup by Component:

    • Software
    • Services

    Breakup by Deployment Type:

    • On-premises
    • Cloud-based

    Breakup by End User:

    • Hospitals
    • Clinics
    • Ambulatory Service Centers
    • Specialty Centers
    • Others

    Breakup by Region:

    • North America
    • Asia-Pacific
    • Europe
    • Latin America
    • Middle East and Africa

    Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/infection-surveillance-solutions-market

    About Us

    IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

    IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

    Contact us:

    IMARC Group
    30 N Gould St, Ste R
    Sheridan, WY (Wyoming) 82801 USA
    Website: https://www.imarcgroup.com
    Email: Sales@imarcgroup.com
    Tel No:(D) +91 120 433 0800
    Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800